{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T08:40:57Z","timestamp":1738312857375,"version":"3.35.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Acquired haemophilia A (AHA) is characterized by the development of autoantibodies against factor VIII, reducing its activity and potentially resulting in bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To assess the characteristics of people with AHA undergoing rehabilitation and\/or with low activities of daily living (ADL) scores, thereby characterizing unmet needs in the management of AHA and informing treatment optimization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>ORIHIME II, the largest epidemiological and treatment survey of AHA in Japan, is a descriptive, retrospective, observational study conducted using health claims data from April 2008 to October 2021. The primary outcome measures were rehabilitation practice and ADL scores on hospital admission and discharge; use of haemostatic agents and immunosuppressive therapy were also assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 427 patients in Japan were eligible for the study. Median (Q1\u2013Q3) age was 78.0 (70.0\u201384.0) years; 264 patients (61.8%) were male. Median (Q1\u2013Q3) time to start rehabilitation was 9 (4\u201321) and 14 (6\u201331) days for those with an admission ADL score of\u00a0&lt;85 and \u226585, respectively. Of the 427 patients, 249 underwent rehabilitation. The most common rehabilitation type was for disuse syndrome; haemostatic agents were more commonly used in patients undergoing earlier rehabilitation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The physical condition of the patient at hospitalization was associated with rehabilitation practice and the ability of the patient to perform day\u2010to\u2010day activities independently. Treatment strategies should be optimized to allow initiation of rehabilitation as early as possible in the course of AHA.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.15132","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:10:48Z","timestamp":1734527448000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real\u2010World Data on Patients With Acquired Haemophilia A in Japan Undergoing Rehabilitation or With Low Activities of Daily Living Scores: The ORIHIME II Study"],"prefix":"10.1111","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-3970","authenticated-orcid":false,"given":"Yoshiyuki","family":"Ogawa","sequence":"first","affiliation":[{"name":"Department of Hematology Gunma University Graduate School of Medicine  Maebashi Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kagehiro","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Tokyo Medical University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Sugao","sequence":"additional","affiliation":[{"name":"Medical Affairs Chugai Pharmaceutical Co., Ltd  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nosaka","sequence":"additional","affiliation":[{"name":"Medical Affairs Chugai Pharmaceutical Co., Ltd  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Murakami","sequence":"additional","affiliation":[{"name":"Medical Affairs Chugai Pharmaceutical Co., Ltd  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Adachi","sequence":"additional","affiliation":[{"name":"Biostatistics Chugai Pharmaceutical Co., Ltd  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-2194","authenticated-orcid":false,"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nara Medical University  Kashihara Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24777"},{"issue":"8","key":"e_1_2_11_3_1","article-title":"Acquired Hemophilia A: A Rare but Potentially Fatal Bleeding Disorder","volume":"11","author":"Yousphi A. S.","year":"2019","journal-title":"Cureus"},{"issue":"3","key":"e_1_2_11_4_1","first-page":"245","article-title":"Acquired Haemophilia A: Italian Consensus Recommendations on Diagnosis, General Management and Treatment of Bleeding","volume":"20","author":"Coppola A.","year":"2022","journal-title":"Blood Transfusion"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230771"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.2491\/jjsth.28.715"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13033"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-587089"},{"issue":"3","key":"e_1_2_11_9_1","first-page":"498","article-title":"Acquired Inhibitors of Clotting Factors: AICE Recommendations for Diagnosis and Management","volume":"13","author":"Franchini M.","year":"2015","journal-title":"Blood Transfusion"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.2491\/jjsth.27.64"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03467-w"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acw049"},{"key":"e_1_2_11_13_1","unstructured":"Medical Data Vision Co. Ltd \u201cMedical Database Overview \u201d(2021) accessed October 2024 https:\/\/www.mdv.co.jp\/press\/2021\/detail_1594.html"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12959"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20200288"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-021-04990-7"},{"issue":"1","key":"e_1_2_11_17_1","first-page":"14","article-title":"Stroke Rehabilitation: Analysis of Repeated Barthel Index Measures","volume":"60","author":"Granger C. V.","year":"1979","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"4","key":"e_1_2_11_18_1","first-page":"145","article-title":"Outcome of Comprehensive Medical Rehabilitation: Measurement by PULSES Profile and the Barthel Index","volume":"60","author":"Granger C. V.","year":"1979","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"2","key":"e_1_2_11_19_1","first-page":"100","article-title":"The Stroke Rehabilitation Outcome Study: Part II. Relative Merits of the Total Barthel Index Score and a Four\u2010Item Subscore in Predicting Patient Outcomes","volume":"70","author":"Granger C. V.","year":"1989","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2210-8"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.2491\/jjsth.19.140"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029850"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04654.x"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S284804"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1682\/JRRD.2012.08.0153"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(00)90095-9"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026141"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-13-107"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2942"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00280-6"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2022.10.004"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.15132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:21:24Z","timestamp":1738214484000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.15132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/hae.15132"],"URL":"https:\/\/doi.org\/10.1111\/hae.15132","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"type":"print","value":"1351-8216"},{"type":"electronic","value":"1365-2516"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"2024-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}